Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew Blumenfeld

Showing results (21-30 of 49) with videos related to

Pageof 5
Sort By:
Headache|November 16, 2011
Bruxism, temporomandibular dysfunction, tension type headache, and migraine: a commentAndrew Blumenfeld, Steven D Bender, Barry Glassman, et al.
BMC Neurology|July 8, 2022
Long-term reductions in disease impact in patients with chronic migraine following preventive treatment with eptinezumabAndrew Blumenfeld, Anders Ettrup, Joe Hirman, et al.
The Journal of Pain|October 5, 2006
A series of three sequential, randomized, controlled studies of repeated treatments with botulinum toxin type A for migraine prophylaxisArthur H Elkind, Philip O'Carroll, Andrew Blumenfeld, et al.
Pain and Therapy|April 21, 2022
Practical Insights on the Identification and Management of Patients with Chronic MigraineAndrew Blumenfeld, Aud Nome Dueland, Stefan Evers, et al.
Headache|June 26, 2024
Long-term effectiveness of eptinezumab in the treatment of patients with chronic migraine and medication-overuse headacheAndrew Blumenfeld, David Kudrow, Peter McAllister, et al.
Frontiers in Neurology|November 15, 2023
Serotonin syndrome in the acute treatment landscape of migraine: the lasmiditan experienceAndrew Blumenfeld, Stewart J Tepper, Rashna Khanna, et al.
Neurology and Therapy|June 2, 2021
Hypervigilance, Allostatic Load, and Migraine Prevention: Antibodies to CGRP or ReceptorAndrew Blumenfeld, Paul L Durham, Alexander Feoktistov, et al.
Headache|October 21, 2010
Method of injection of onabotulinumtoxinA for chronic migraine: a safe, well-tolerated, and effective treatment paradigm based on the PREEMPT clinical programAndrew Blumenfeld, Stephen D Silberstein, David W Dodick, et al.
Headache|August 20, 2005
Burden of illness and satisfaction with care among patients with headache seen in a primary care settingLinda H Harpole, Gregory P Samsa, David B Matchar, et al.
Headache|August 28, 2024
Healthcare resource use and costs associated with the misdiagnosis of migraineJae Rok Kim, Tae Jin Park, Maria Agapova, et al.
Pageof 5

Showing results (21-30 of 49) with videos related to

Sort By:
Pageof 5
Headache|November 16, 2011
Bruxism, temporomandibular dysfunction, tension type headache, and migraine: a commentAndrew Blumenfeld, Steven D Bender, Barry Glassman, et al.
BMC Neurology|July 8, 2022
Long-term reductions in disease impact in patients with chronic migraine following preventive treatment with eptinezumabAndrew Blumenfeld, Anders Ettrup, Joe Hirman, et al.
The Journal of Pain|October 5, 2006
A series of three sequential, randomized, controlled studies of repeated treatments with botulinum toxin type A for migraine prophylaxisArthur H Elkind, Philip O'Carroll, Andrew Blumenfeld, et al.
Pain and Therapy|April 21, 2022
Practical Insights on the Identification and Management of Patients with Chronic MigraineAndrew Blumenfeld, Aud Nome Dueland, Stefan Evers, et al.
Headache|June 26, 2024
Long-term effectiveness of eptinezumab in the treatment of patients with chronic migraine and medication-overuse headacheAndrew Blumenfeld, David Kudrow, Peter McAllister, et al.
Frontiers in Neurology|November 15, 2023
Serotonin syndrome in the acute treatment landscape of migraine: the lasmiditan experienceAndrew Blumenfeld, Stewart J Tepper, Rashna Khanna, et al.
Neurology and Therapy|June 2, 2021
Hypervigilance, Allostatic Load, and Migraine Prevention: Antibodies to CGRP or ReceptorAndrew Blumenfeld, Paul L Durham, Alexander Feoktistov, et al.
Headache|October 21, 2010
Method of injection of onabotulinumtoxinA for chronic migraine: a safe, well-tolerated, and effective treatment paradigm based on the PREEMPT clinical programAndrew Blumenfeld, Stephen D Silberstein, David W Dodick, et al.
Headache|August 20, 2005
Burden of illness and satisfaction with care among patients with headache seen in a primary care settingLinda H Harpole, Gregory P Samsa, David B Matchar, et al.
Headache|August 28, 2024
Healthcare resource use and costs associated with the misdiagnosis of migraineJae Rok Kim, Tae Jin Park, Maria Agapova, et al.
Pageof 5